September 20, 2016 06:42 AM EDTUpdated 11:04 AM
People
Bioregnum
Opinion

GSK makes a lit­tle his­to­ry while out­lin­ing a fa­mil­iar fu­ture

Glax­o­SmithK­line made phar­ma his­to­ry to­day by ap­point­ing Em­ma Walm­s­ley as the first woman to run a glob­al drug mak­er. And she will have to …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Ab­b­Vie dou­bles down on siR­NA with $335M up­front bet on ADARx

GSK to pay $1.2B up­front to snag Boston Phar­ma’s mid-stage MASH hope

No­vo turns to Septer­na for oral obe­si­ty med­i­cines in deal worth up to $2.2B

SK, Car­lyle bol­ster blue­bird bio bid; Theri­ni Bio rais­es $39M

Lack of de­tail in Trump's drug price plan rais­es more ques­tions than an­swers

PBM over­haul and drug price ne­go­ti­a­tions make the cut in Re­pub­li­can­s' tax bill

A service from the Financial Times